Divis Labs gains as Motilal Oswal stays cautious
In short
Divis Labs shares rose 7% on Muhurat Trading day. CNBC TV18 says Motilal Oswal still stayed on the sidelines, even while noting the company’s strengths in custom synthesis, peptides, contrast media, generics, manufacturing and supply chain management.
This matters to investors because the stock moved sharply, but the brokerage tone stayed cautious.
What the reporting says
Divis Laboratories shares surged 7% on Muhurat Trading day, while Motilal Oswal remained on the sidelines, according to a CNBC TV18 Market summary. The broker said the company is well-positioned in custom synthesis because of its strengths in peptides, contrast media, generics, large-scale manufacturing and supply chain management.
Why it matters
Divis Laboratories shares rose 7% on Muhurat Trading day, while Motilal Oswal kept a cautious stance. The broker’s view highlighted Divis’s position in custom synthesis and its capabilities across peptides, contrast media, generics, manufacturing and supply chain management. The brief suggests investor interest in the stock, even as the brokerage did not move off the sidelines.